|
Tularemia Animal Model Qualification Working Group
|
Committee, Work group, Advisory group, or Task Force
|
FDA
|
NIAID
|
This working group is collaborating on qualification of primate model of pneumonic tularemia under FDA''s Animal Model Qualification/Drug Development Tools Program. Animal model qualification is a regulatory decision and will be published on the FDA web site when final. Collaboration includes exchange of study data, study reports, and agreements on regulatory strategy for model qualification.
|
|
U. S. Government Interagency Working Group on Nanotechnology Environmental, and Health Implications (NEHI), of the Nanoscale Science, Engineering, and Technology Subcommittee (NSET) of the National Science and Technology Council (NSTC)
|
Committee, Work group, Advisory group, or Task Force
|
CDC, FDA
|
NCI, NIEHS
|
The Nanoscale Science, Engineering, and Technology (NSET) Subcommittee and Nanotechnology Environmental, and Health Implications (NEHI) Working Group provide leadership in establishing the national nanotechnology environmental, health, and safety research agenda and in communicating data and information related to environmental and health aspects of nanotechnology between National Nanotechnology Initiative (NNI) agencies and with the public. NNI activities support the development of new tools and methods required for the research that will enable risk analysis and assist in regulatory decision-making. NNI agencies engage and interact with regional, state, and local groups, educational institutions, industry-supported groups, and non-governmental organizations to enhance the impact and value of NNI efforts and to provide a collaborative approach.
|
|
U.S. Preventive Services Task Force (USPSTF)
|
Resource Development
|
AHRQ
|
NCI, OD/DPCPSI/ODP
|
The U.S. Preventive Services Task Force (USPSTF) is an independent panel of non-Federal experts in prevention and evidence-based medicine and is composed of primary care providers. The USPSTF conducts scientific evidence reviews of a broad range of clinical preventive health care services (such as screening, counseling, and preventive medications) and develops recommendations for primary care clinicians and health systems that are published in the form of "Recommendation Statements."
|
|
U.S.-Brazil Joint Commission Meeting on Science and Technology - Working Group on Public Health
|
Meeting/ Workshop
|
CDC, OS
|
NIAID, NCI
|
The Working Group on Public Health was established under the Joint Commission Meeting (JCM) to identify and address public health issues of mutual interest and priority. JCMS are collaborative agreements with foreign governments in fields of science and technology and are established by the U.S. Department of State.
|
|
U.S.-Uzbekistan Joint Committee Meeting (JCM) for Science & Technology Cooperation
|
Meeting/ Workshop
|
FDA
|
NIAID, NCI
|
This collaboration was in furtherance of the 2010 U.S.-Uzbekistan Science and Technology Agreement, signed by then Secretary of State Hillary Clinton and First Deputy Prime Minister Rustam Azimov. Approximately 30 U.S. scientists, university researchers, and representatives from both government and non-profit agencies attended, along with approximately 60 Uzbek scientists, researchers, and government officials. The aim of the Joint Committee Meeting (JCM) was to define two-year action plans for cooperation in three mutually-identified areas: agriculture, renewable energy, and evidence-based medicine.
|
|
Understanding and Identifying the Needs for Medical Devices
|
Committee, Work group, Advisory group, or Task Force
|
FDA
|
NCATS
|
The Institute of Medicine Rare Diseases and Orphan Products 2010 Report recommended that the FDA and NIH perform an assessment of unmet devices needs, and determine the impediments, and options for overcoming these impediments. The assessment will document examples of compelling unmet needs across sections of medical specialties culminating in a report and publication. Collaborating are the Office of rare Diseases Research at NCATS, and the Office of Orphan Product Development and other parts of the FDA.
|
|
Unified Medical Language System Metathesaurus (UMLS)
|
Resource Development
|
AHRQ, CDC, CMS, FDA
|
NLM
|
NLM''s Unified Medical Language System (UMLS®) facilitates the development of computer systems that behave as if they understand the meaning of the language of biomedicine and health. To that end, NLM produces and distributes the UMLS Knowledge Sources (databases) and associated software tools (programs) for use by system developers in building or enhancing electronic information systems that create, process, retrieve, integrate, and/or aggregate biomedical and health data and information, as well as in informatics research. By design, the UMLS Knowledge Sources are multi-purpose.
|
|
Urology Interagency Coordinating Committee
|
Committee, Work group, Advisory group, or Task Force
|
AHRQ, CDC, CMS, FDA
|
NCCIH, NCI, NIA, NICHD, NIDDK, NINDS
|
Public law 99-158 establishes a need for the Urology Interagency Coordinating Committee and emphasizes the importance of interagency coordinating meetings. Meetings focus on interagency collaboration to elicit ideas from meeting participants to enhance current research directions within the National Institutes of Health and form partnerships among agencies.
|
|
US Public Health Service (USPHS) Physicians Professional Advisory Committee (PPAC)
|
Committee, Work group, Advisory group, or Task Force
|
CDC, CMS, FDA
|
NIAID
|
The purpose of this committee is to provide advice and consultation to the Surgeon General on issues relating to the professional practice and personnel activities, civil service, and Commissioned Corps of the Medical Category.
Provides advisory assistance to the Chief Professional Officer and to the Agency and/or Program Heads of the USPHS and to non-PHS programs that routinely use USPHS personnel.
|
|
Value Set Authority Center (VSAC)
|
Resource Development
|
AHRQ, CDC, CMS, OS
|
NLM
|
The National Library of Medicine (NLM) provides an online repository of value sets (code sets from standardized medical vocabularies) that are used for clinical quality measurement in the CMS EHR Incentive Program (meaningful use). The Value Set Authority Center (VSAC) provides downloadable access to all official versions of vocabulary value sets contained in the 2014 Clinical Quality Measures (CQMs). Each value set consists of the numerical values (codes) and human-readable names (terms), drawn from standard vocabularies such as SNOMED CT® , RxNorm, LOINC and ICD-10-CM, which are used to define clinical concepts used in clinical quality measures (e.g., patients with diabetes, clinical visit).
|